Literature DB >> 11104221

Modafinil treatment of pramipexole-associated somnolence.

R A Hauser1, M N Wahba, T A Zesiewicz, W McDowell Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11104221     DOI： 10.1002/1531-8257(200011)15:6<1269::aid-mds1036>3.0.co;2-r

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  11 in total

1.  Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial.

Authors:  W G Ondo; R Fayle; F Atassi; J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

Review 2.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

3.  Sleepiness and Unintended Sleep in Parkinson's Disease.

Authors:  David B. Rye
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

Review 4.  Agitation and psychosis associated with dementia with lewy bodies exacerbated by modafinil use.

Authors:  Eduardo Prado; Pongsatorn Paholpak; Myha Ngo; Verna Porter; Liana G Apostolova; Rogério Marrocos; John M Ringman
Journal:  Am J Alzheimers Dis Other Demen       Date:  2012-08-14       Impact factor: 2.035

Review 5.  Dopamine receptor agonists for the treatment of early or advanced Parkinson's disease.

Authors:  Santiago Perez-Lloret; Olivier Rascol
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

6.  Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers.

Authors:  R H Hou; C Freeman; R W Langley; E Szabadi; C M Bradshaw
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

Review 7.  Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?

Authors:  Theresa A Zesiewicz; Robert A Hauser
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 8.  Excessive daytime sleepiness and unintended sleep in Parkinson's disease.

Authors:  David B Rye
Journal:  Curr Neurol Neurosci Rep       Date:  2006-03       Impact factor: 5.081

Review 9.  Treatment of narcolepsy and other hypersomnias of central origin.

Authors:  Merrill S Wise; Donna L Arand; R Robert Auger; Stephen N Brooks; Nathaniel F Watson
Journal:  Sleep       Date:  2007-12       Impact factor: 5.849

10.  Treatment of advanced Parkinson's disease.

Authors:  Sara Varanese; Zoe Birnbaum; Roger Rossi; Alessandro Di Rocco
Journal:  Parkinsons Dis       Date:  2011-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.